Tag: clinical validation
-
Liver Cancer Early Detection Gets a Boost from ALTUS Blood Test Study
Groundbreaking ALTUS Study Highlights Blood-Based Liver Cancer Detection Exact Sciences Corp. today announced pivotal validation results from the ALTUS study (NCT: 05064553), a prospective, head-to-head evaluation of a blood-based surveillance test for liver cancer detection. The findings, presented by the company in Madison, Wisconsin, suggest clear improvements in identifying liver cancer at an earlier, more…
-
Exact Sciences Unveils Breakthrough Blood Test for Early Liver Cancer Detection
Groundbreaking Validation of a Blood-Based Liver Cancer Screening Tool Exact Sciences Corp. has announced pivotal clinical validation results from the ALTUS study, a prospective, head-to-head evaluation designed to assess a blood-based surveillance test for liver cancer. Conducted in a real-world, high-risk population, the ALTUS study (NCT: 05064553) represents a major step toward accessible, non-invasive screening…
-
Exact Sciences Unveils Breakthrough: Blood-Based Test Boosts Early Liver Cancer Detection
Breakthrough in Liver Cancer Detection Exact Sciences Corp. announced pivotal clinical validation results from the ALTUS study, signaling a major step forward in the early detection of liver cancer through a blood-based surveillance test. The prospective, head-to-head study (NCT: 05064553) evaluated the test’s performance against existing screening modalities, with results indicating superior sensitivity and specificity…
-
Scientists unveil first “accurate blood test” to diagnose chronic fatigue syndrome (ME/CFS)
Groundbreaking Claim: A Blood Test for ME/CFS Scientists from the University of East Anglia (UEA) and Oxford Biodynamics (OBD) say they have developed what could be the world’s first blood test capable of diagnosing myalgic encephalomyelitis, commonly known as chronic fatigue syndrome or ME/CFS. If validated, the test would represent a major shift in how…